Franklin Genomic Advancements ETF (BATS:HELX) Short Interest Update

Franklin Genomic Advancements ETF (BATS:HELX) saw a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 4,118 shares, a decrease of 74.2% from the June 30th total of 15,981 shares. Approximately 1.0% of the company’s shares are short sold. Based on an average daily volume of 3,276 shares, the days-to-cover ratio is currently 1.3 days.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. LPL Financial LLC increased its stake in Franklin Genomic Advancements ETF by 22.4% in the fourth quarter. LPL Financial LLC now owns 11,133 shares of the company’s stock valued at $404,000 after purchasing an additional 2,037 shares in the last quarter. Osaic Holdings Inc. boosted its position in shares of Franklin Genomic Advancements ETF by 19.1% during the second quarter. Osaic Holdings Inc. now owns 3,132 shares of the company’s stock worth $87,000 after purchasing an additional 502 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Franklin Genomic Advancements ETF during the second quarter worth $42,000. Finally, Kestra Advisory Services LLC bought a new position in shares of Franklin Genomic Advancements ETF during the fourth quarter worth $39,000.

Franklin Genomic Advancements ETF Stock Down 0.3%

BATS:HELX opened at $38.85 on Friday. Franklin Genomic Advancements ETF has a 12-month low of $27.54 and a 12-month high of $41.30. The firm has a market capitalization of $15.54 million, a P/E ratio of 26.71 and a beta of 1.05. The stock’s fifty day simple moving average is $37.20 and its 200-day simple moving average is $35.44.

About Franklin Genomic Advancements ETF

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.